Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers.
AUTOR(ES)
Zerial, A
RESUMO
A synthetic compound, 2-[(1,5,10,10a-tetrahydro-3H-thiazolo[3,4b]isoquinolin-3-ylidene) amino]-4-thiazoleacetic acid (S), 44 081 R.P., inhibits the multiplication of rhinoviruses in cell cultures. Of the 69 rhinovirus strains and serotypes that have been studied, 39% were inhibited at a concentration of 7 micrograms/ml, far below that which affects cellular metabolism (250 micrograms/ml). Preliminary data indicate that the compound inhibits some early events of virus replication but that some cellular functions are also involved in its mechanism of action. Despite its antiviral activity in vitro, the compound, when self-administered intranasally as a 0.2% solution to volunteers from the day before to 5 days after inoculation with a human rhinovirus strain, had no significant effect on rhinorrhea, clinical score, or laboratory evidence of infection.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=180164Documentos Relacionados
- Antirhinovirus compound 44,081 R.P. inhibits virus uncoating.
- Effects of atropine on autonomic indices based on electrocardiographic R-R intervals in healthy volunteers.
- Pharmacokinetic studies with dibekacin, a new aminoglycoside, after intravenous and intramuscular administration to human volunteers.
- EFFECTIVENESS OF A NEW COMPOUND, BENEMID, IN ELEVATING SERUM PENICILLIN CONCENTRATIONS
- Suppression of adjuvant arthritis by a new cytotoxic compound, rubidomycin.
